Please download the brochure “No more excuses” and read more about female experts in Europe, and about AcademiaNet. After his doctoral thesis Institute of Zoology, TiHo he worked as contract researcher and gained experiences in the field of studies for pharmaceutical and biomedical industry under GLP conditions. In he became the authorized representative of the HZI business management. Analysis from body fluids. Final exam of Susann Santag on September 26, Periostin secreted by mesenchymal stem cells supports tendon formation in an ectopic mouse model.
Summer School Stockholm He was appointed Chief Operations Officer in Christine Hoffmann studied pharmacy in Braunschweig and is a certified pharmacist since Moreover, as quality management representative he supports the introduction of a quality management system according to ISO at the Department of Otolaryngology which is planned for Currently, he is group leader at the Institute of Pharmaceutical Technology in Braunschweig and visiting professor for Pharmaceutical Technology and Biopharmaceutics at the University of Hamburg.
The goal is to develop new therapeutic and preventive antiviral strategies. Scine she worked at the Institute for Transfusion Medicine with a strong focus in the establishment of allogeneic cell-based therapies.
Weigt joined LipoNova AG. In Christoph Priesner changed to a biotech company in Hannover as a team leader and later Head of Quality Control and Qualified Person, involved in the development and manufacture of medicinal standard products as well as of advanced therapy investigational medicinal products ATIMPboth derived from human tissue and blood. Final exam of Endrit Elbasani August 18, Final exam of Eugenia Gripp June 5, Final exam of Sarah Horst on December 21, The phosphate source influences gene expression and quality of mineralization during in vitro osteogenic differentiation of human mesenchymal stem cells.
Sinceshe is group leader with major interests in blood pharming large-scale in vitro production of blood cell components and the reduction of immunogenicity of allogeneic cell-based products to prevent rejection after transplantation. During a postdoctoral and research assistant phase and at the University Hospital of Zurich, he worked in the laboratory of Nobel laureate Rolf Zinkernagel.
Final exam of Sebastian Lunemann on January 22, Identification as prostaglandin-D synthase”. Amongst others he participated in major research collaborations with Ono Pharmaceutical, Cubist Pharmaceuticals, Bayer, Genentech and later major US universities and dissertatoin institutions.
Speakers | TRAIN
Final exam of Sandra Billig May 31, As founder and CEO of a startup company and manager of a university clinic for heart surgery with an annual turnover of approximately 70 million Euros and about employees, he can look back on countless successful but also non-successful mhj. Summer School Timmendorfer Strand His recent focus is on translational non-coding RNA research and development of microRNA therapeutics in heart failure.
Since he is a full professor W2 for clinical pharmacology — early clinical trials and drug research at Hannover Medical School. Primary school, gymnasium grammar school in Hannover, Germany; awarded the Dissertatiln A-levels with top marks 1,0.
Prof. Dr. Andrea Hoffmann
He moved to the pharmaceutically regulated field in while pursuing his dissertation on the production and quality control of cell therapy products according to GMP which were subsequently clinically tested. His work focuses on structural, functional and clinical research of the human MHC mh allogeneic, adoptive and regenerative cell therapy including genetic engineering of primary cells and stem cells to decrease their immunogenicity.
Final exam of Anne Lorenz September 3, Before and during her studies she worked as an intensive care nurse at Hannover Medical School. Moreover, as quality management representative he supports the introduction of a quality management system according to ISO at the Department of Otolaryngology which is planned for Continuing education for safety officers in genetic engineering safety, head of disserhation engineering projects safety levels 1 and 2 Reviewer for journals, for the Alexander von Humboldt Foundation, the German Research Foundation DFGthe University of Missouri.
Prof. Dr. Andrea Hoffmann – AcademiaNet
Furthermore, he has done research in clinical ethics, i. He dissertatioj published more than reports in international journals. Carmen Puschmann has been working at corlife oHG since Final exam of Lynn Kennemann on April 5, Gygi at Harvard Medical School in She is a member of numerous national and international societies jhh is serving as a reviewer for the European Medicine Agency. Final exam of Tharini Ashtalakshmi Selvakumar June 4, Gerdelmann worked, after completing his studies of biology, for nearly ten years as postgraduate and post-doc in scientific research at medical disertation biophysical university institutes.
In he founded an internet company with a focus on internet marketing and eCommerce, in which he —is still active as a partner and advisor today.
In his own group, he is currently investigating antiviral immunity and viral immune evasion. A key focus of his activities is the question of leadership as a strategic resource.
Since founding of corlife in Carmen Puschmann has been active in the field of development and regulatory affairs of medical devices.